Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Ozempic (semaglutide for diabetes) is an example of an older, established GLP-1 that demonstrated weight loss effectiveness before Wegovy (semaglutide for obesity) launched
27 September 2018
GLP-1 Market Size and Forecast 2026 to 2035 The global GLP-1 market size accounted for USD 58.40 billion in 2025 and is predicted to increase from USD 66.46 billion in 2026 to approximately USD 212.73 billion by 2035, expanding at a CAGR of 13.80% from 2026 to 2035
It builds on the foundation laid by semaglutide and tirzepatide but adds the glucagon receptor component that may explain its superior weight loss outcomes
Discuss any supplements or other weight loss medications with Dr
